dactinomycin has been researched along with Sclerosis, Systemic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihn, H; Tamaki, K; Yamane, K | 1 |
| Ochs, RL; Press, RI | 1 |
| Busch, H; Lischwe, MA; Ochs, RL; Spohn, WH | 1 |
| Peters, JM; Reimer, G; Scheer, U; Tan, EM | 1 |
| Anderer, FA; Franke, M; Pfeifle, J | 1 |
| Drexler, E; Hanson, V; Johnson, GD; Kornreich, HK; Macpherson, GA | 1 |
6 other study(ies) available for dactinomycin and Sclerosis, Systemic
| Article | Year |
|---|---|
Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblast
Topics: Androstadienes; Cells, Cultured; Chromones; Dactinomycin; Dermis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Growth Factor; Fibroblasts; Humans; Morpholines; Nucleic Acid Synthesis Inhibitors; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA, Messenger; Scleroderma, Systemic; Signal Transduction; Transfection; Up-Regulation; Wortmannin | 2003 |
Centromere autoantigens are associated with the nucleolus.
Topics: Autoantigens; Cell Nucleolus; Centromere; Dactinomycin; Fluorescent Antibody Technique; HeLa Cells; Humans; Interphase; Microscopy, Electron; Molecular Weight; Scleroderma, Systemic | 1992 |
Fibrillarin: a new protein of the nucleolus identified by autoimmune sera.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Reactions; Cell Nucleolus; Chromosomal Proteins, Non-Histone; Dactinomycin; Dipodomys; Fibroblasts; Fluorescent Antibody Technique; HeLa Cells; Humans; Immune Sera; Immunoenzyme Techniques; Interphase; Kidney; Lymphocytes; Mice; Microscopy, Electron; Nuclear Proteins; Nucleophosmin; Rats; Ribonucleoproteins; Scleroderma, Systemic; Xenopus | 1985 |
Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
Topics: Animals; Antigens, Nuclear; Autoantibodies; Autoantigens; Cell Cycle; Cell Nucleolus; Dactinomycin; Dichlororibofuranosylbenzimidazole; Fluorescent Antibody Technique; HeLa Cells; Humans; Myositis; Nucleoproteins; Scleroderma, Systemic; Vero Cells | 1986 |
Characterisation of nucleolar proteins as autoantigens using human autoimmune sera.
Topics: Animals; Antibodies, Antinuclear; Arthritis, Rheumatoid; Chromatography, Affinity; Cross Reactions; Dactinomycin; Fluorescent Antibody Technique; Humans; Mice; Nuclear Proteins; Nucleophosmin; Ribonucleases; Ribonucleoproteins; Scleroderma, Systemic | 1986 |
Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
Topics: Adolescent; Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Arthritis, Juvenile; Child; Child, Preschool; Dactinomycin; Dermatomyositis; DNA; Female; Fluorescent Antibody Technique; Humans; Immunodiffusion; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Infant; Lupus Erythematosus, Systemic; Male; Radioimmunoassay; Scleroderma, Localized; Scleroderma, Systemic; Tritium | 1974 |